Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.
At the present time, imaging guided renal biopsy is used to provide diagnoses in most types of primary and secondary renal diseases. It has been claimed that renal biopsy can provide a link between diagnosis of renal disease and its pathological conditions. However, sometimes there is a considerable mismatch between patient renal outcome and pathological findings in renal biopsy. This is the time to address some new diagnostic methods to resolve the insufficiency of conventional percutaneous guided renal biopsy. Nanotechnology is still in its infancy in renal imaging; however, it seems that it is the next step in renal biopsy, providing solutions to the limitations of conventional modalities.
Department of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Hamid Tayebi
HT
Khosroshahi
Medical Bioengineering Department, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Behzad
0000-0001-7676-4291
B
Abedi
Medical Bioengineering Department, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran.
Sabalan
0000-0002-8258-0437
S
Daneshvar
School of Engineering-Emerging Technologies, University of Tabriz, Tabriz, Iran.
Yashar
Y
Sarbaz
Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Abolhassan
A
Shakeri Bavil